04:20 AM EDT, 07/01/2024 (MT Newswires) -- Sanofi ( SNY ) is close to deciding on an investment of between 1.3 billion euros and 1.5 billion euros ($1.40 billion to $1.61 billion) at a key production site in Frankfurt, Germany, where it manufactures insulin, German newspaper Handelsblatt reported Monday.

Sanofi ( SNY ) initially considered moving certain insulin production to France but eventually settled on an upgrade of the German facility, the report said, citing German government sources.

Sanofi ( SNY ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)